(1) MBL-a/c were found to accumulate in the brain after stroke peaking at 24 h. (2) MBL−/− improved acute (day 1) but not subacute (day 7) measures of infarct volume and neurological deficit. The gene discussed is MBL2; the disease is stroke disorder.